About This Trial
Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections (ACCUTE)
- Status: Enrolling now
- Location: Miami Valley Hospital
- Study type: Interventional
- Ages eligible for study: 18 and older
- Genders eligible for study: Both
- Principal Investigator: Akpofure Peter Ekeh, M.D.
- For more information about this study, visit ClinicalTrials.gov: NCT02469857
If you would like information about participating in this study, contact:
Contact Us
Linda Clark, MSN, RN
937-208-2913
lclark@premierhealth.com